Articles by Brian K Agan, MD

Early Postseroconversion CD4 Cell Counts Independently Predict CD4 Cell Count Recovery in HIV-1–Postive Subjects Receiving Antiretroviral Therapy

Kulkarni, Hemant; Okulicz, Jason F; Grandits, Greg; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 57(5):387-395, August 15th, 2011.

Elevated CD8 Counts During HAART Are Associated With HIV Virologic Treatment Failure

Krantz, Elizabeth M; Hullsiek, Katherine Huppler; Okulicz, Jason F; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 57(5):396-403, August 15th, 2011.

Medical Encounter Characteristics of HIV Seroconverters in the US Army and Air Force, 2000–2004

Hakre, Shilpa; Brett-Major, David M; Singer, Darrell E; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(4):372-380, April 2011.

Risk Factors Influencing Antibody Responses to Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Antigens in Patients Under Antiretroviral Therapy

Guadalupe, Moraima; Pollock, Brad H; Westbrook, Steven; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(1):83-90, January 1st, 2011.

Virologic Response Differences Between African Americans and European Americans Initiating Highly Active Antiretroviral Therapy With Equal Access to Care

Weintrob, Amy C; Grandits, Greg A; Agan, Brian K; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 52(5):574-580, December 2009.

Increasing Age at HIV Seroconversion From 18 to 40 Years Is Associated With Favorable Virologic and Immunologic Responses to HAART

Weintrob, Amy C; Fieberg, Ann M; Agan, Brian K; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 49(1):40-47, September 1st, 2008.

Comparisons of Causes of Death and Mortality Rates Among HIV-Infected Persons: Analysis of the Pre-, Early, and Late HAART (Highly Active Antiretroviral Therapy) Eras

Crum, Nancy F; Riffenburgh, Robert H; Wegner, Scott; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 41(2):194-200, February 1st, 2006.